These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3501541

  • 1. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ, Madajewicz S, Herrera L, Rustum YM, Trave F, Creaven P, Mittelman A.
    NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
    [Abstract] [Full Text] [Related]

  • 2. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Tixi LM, Bolli EA, Rosso R, Mammoliti S, Rollandi GA, Bertoglio S.
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [Abstract] [Full Text] [Related]

  • 3. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin.
    Arbuck SG, Douglass HO, Trave F, Rustum YM.
    NCI Monogr; 1987 Sep; (5):203-5. PubMed ID: 3501544
    [Abstract] [Full Text] [Related]

  • 4. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
    Valone FH, Kohler M, Fisher K, Hannigan J, Flam M, Gandara D, Hendrickson C, Richman E, Yu KP.
    NCI Monogr; 1987 Sep; (5):175-7. PubMed ID: 2963230
    [Abstract] [Full Text] [Related]

  • 5. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
    O'Connell MJ, Klaassen DJ, Everson LK, Cullinan S, Wieand HS.
    NCI Monogr; 1987 Sep; (5):185-8. PubMed ID: 3501540
    [Abstract] [Full Text] [Related]

  • 6. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Benavides M, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L.
    NCI Monogr; 1987 Sep; (5):193-8. PubMed ID: 3501542
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 Sep; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 15; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1100-5. PubMed ID: 9070486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.
    Bruckner HW, Petrelli NJ, Stablein D, Novak J, Mayer R.
    NCI Monogr; 1987 Mar 15; (5):179-84. PubMed ID: 3501539
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.